Glaukos PE Ratio 2014-2025 | GKOS
Current and historical p/e ratio for Glaukos (GKOS) from 2014 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Glaukos PE ratio as of May 20, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Glaukos PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-21 | 94.82 | 0.00 | |
| 2025-03-31 | 98.42 | $-2.37 | 0.00 |
| 2024-12-31 | 149.94 | $-2.87 | 0.00 |
| 2024-09-30 | 130.28 | $-3.02 | 0.00 |
| 2024-06-30 | 118.35 | $-3.26 | 0.00 |
| 2024-03-31 | 94.29 | $-2.88 | 0.00 |
| 2023-12-31 | 79.49 | $-2.78 | 0.00 |
| 2023-09-30 | 75.25 | $-2.69 | 0.00 |
| 2023-06-30 | 71.21 | $-2.64 | 0.00 |
| 2023-03-31 | 50.10 | $-2.92 | 0.00 |
| 2022-12-31 | 43.68 | $-2.09 | 0.00 |
| 2022-09-30 | 53.24 | $-1.90 | 0.00 |
| 2022-06-30 | 45.42 | $-1.19 | 0.00 |
| 2022-03-31 | 57.82 | $-0.61 | 0.00 |
| 2021-12-31 | 44.44 | $-1.08 | 0.00 |
| 2021-09-30 | 48.17 | $-0.85 | 0.00 |
| 2021-06-30 | 84.83 | $-1.33 | 0.00 |
| 2021-03-31 | 83.93 | $-1.85 | 0.00 |
| 2020-12-31 | 75.26 | $-2.73 | 0.00 |
| 2020-09-30 | 49.52 | $-1.65 | 0.00 |
| 2020-06-30 | 38.42 | $-1.67 | 0.00 |
| 2020-03-31 | 30.86 | $-0.94 | 0.00 |
| 2019-12-31 | 54.47 | $0.26 | 209.50 |
| 2019-09-30 | 62.51 | $-0.54 | 0.00 |
| 2019-06-30 | 75.40 | $-0.36 | 0.00 |
| 2019-03-31 | 78.37 | $-0.34 | 0.00 |
| 2018-12-31 | 56.17 | $-0.38 | 0.00 |
| 2018-09-30 | 64.90 | $-0.39 | 0.00 |
| 2018-06-30 | 40.64 | $-0.16 | 0.00 |
| 2018-03-31 | 30.83 | $-0.11 | 0.00 |
| 2017-12-31 | 25.65 | $-0.01 | 0.00 |
| 2017-09-30 | 33.00 | $-0.04 | 0.00 |
| 2017-06-30 | 41.47 | $-0.05 | 0.00 |
| 2017-03-31 | 51.30 | $0.11 | 466.36 |
| 2016-12-31 | 34.30 | $0.12 | 285.83 |
| 2016-09-30 | 37.74 | $0.05 | 754.80 |
| 2016-06-30 | 29.16 | $-0.05 | 0.00 |
| 2016-03-31 | 16.86 | $-1.41 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.571B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.696B | 87.47 |
| Thermo Fisher Scientific (TMO) | United States | $156.188B | 18.89 |
| Edwards Lifesciences (EW) | United States | $45.655B | 29.93 |
| Alcon (ALC) | Switzerland | $43.440B | 29.36 |
| IDEXX Laboratories (IDXX) | United States | $41.591B | 47.80 |
| DexCom (DXCM) | United States | $34.247B | 52.93 |
| IQVIA Holdings (IQV) | United States | $25.076B | 14.05 |
| Mettler-Toledo (MTD) | United States | $24.648B | 29.31 |
| STERIS (STE) | Ireland | $24.609B | 27.14 |
| Waters (WAT) | United States | $21.548B | 30.40 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.213B | 0.00 |
| Hologic (HOLX) | United States | $12.584B | 13.67 |
| Penumbra (PEN) | United States | $10.887B | 85.45 |
| Sysmex ADR (SSMXY) | Japan | $10.571B | 29.99 |
| Globus Medical (GMED) | United States | $8.473B | 19.87 |
| Masimo (MASI) | United States | $8.467B | 31.23 |
| Teleflex (TFX) | United States | $5.606B | 9.25 |
| Integer Holdings (ITGR) | United States | $4.243B | 22.23 |
| TransMedics (TMDX) | United States | $4.218B | 91.70 |
| PROCEPT BioRobotics (PRCT) | United States | $3.274B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.447B | 14.57 |
| Veracyte (VCYT) | United States | $2.256B | 31.66 |
| Elekta AB (EKTAY) | Sweden | $2.106B | 18.93 |
| Nihon Kohden (NHNKY) | Japan | $2.058B | 23.60 |
| Alphatec Holdings (ATEC) | United States | $1.896B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.567B | 0.00 |
| Artivion (AORT) | United States | $1.246B | 116.68 |
| Pulse Biosciences (PLSE) | United States | $1.148B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.035B | 5.50 |
| SiBone (SIBN) | United States | $0.840B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.687B | 0.00 |
| IRadimed (IRMD) | United States | $0.678B | 34.38 |
| RxSight (RXST) | United States | $0.675B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.627B | 13.70 |
| Delcath Systems (DCTH) | United States | $0.626B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.606B | 9.42 |
| NeuroPace (NPCE) | United States | $0.590B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.556B | 0.00 |
| AxoGen (AXGN) | United States | $0.527B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.468B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.467B | 12.43 |
| Treace Medical Concepts (TMCI) | United States | $0.421B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.386B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.358B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.306B | 0.00 |
| Neuronetics (STIM) | United States | $0.282B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.242B | 14.65 |
| Alpha Tau Medical (DRTS) | Israel | $0.229B | 0.00 |
| CVRx (CVRX) | United States | $0.182B | 0.00 |
| Accuray (ARAY) | United States | $0.179B | 0.00 |
| 908 Devices (MASS) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.169B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.141B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.140B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.138B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.122B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.099B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.095B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.084B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.00 |
| EDAP TMS S.A (EDAP) | France | $0.071B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.056B | 17.08 |
| Hyperfine (HYPR) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Envoy Medical (COCH) | United States | $0.037B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.033B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 17.06 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |